BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report issued on Saturday. The firm set a “sell” rating on the medical technology company’s stock.

A number of other equities analysts also recently commented on the stock. Benchmark reaffirmed a “speculative buy” rating and issued a $0.40 price objective on shares of BIOLASE in a report on Wednesday, October 2nd. Ascendiant Capital Markets decreased their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd.

BIOLASE Stock Performance

Shares of NASDAQ:BIOL opened at $0.01 on Friday. The company has a fifty day simple moving average of $0.05 and a 200 day simple moving average of $0.10. The firm has a market cap of $384,180.50, a PE ratio of 0.00 and a beta of 0.67. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94.

BIOLASE (NASDAQ:BIOL) last issued its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $11.56 million during the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%.

Hedge Funds Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the quarter. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent filing with the SEC. 8.79% of the stock is owned by institutional investors and hedge funds.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.